EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 255 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $123,568 | -58.7% | 13,931 | -43.0% | 0.07% | -60.9% |
| Q3 2022 | $299,000 | -73.3% | 24,419 | -74.2% | 0.18% | -72.6% |
| Q2 2022 | $1,120,000 | -61.8% | 94,703 | -38.6% | 0.67% | -52.8% |
| Q1 2022 | $2,934,000 | +90.9% | 154,254 | +73.6% | 1.42% | +74.6% |
| Q4 2021 | $1,537,000 | -54.5% | 88,873 | +8.1% | 0.82% | -43.4% |
| Q3 2021 | $3,378,000 | -15.2% | 82,234 | +16.9% | 1.44% | -25.9% |
| Q2 2021 | $3,985,000 | +45.8% | 70,364 | +8.1% | 1.94% | +31.4% |
| Q1 2021 | $2,734,000 | -44.2% | 65,084 | +19.2% | 1.48% | -42.0% |
| Q4 2020 | $4,897,000 | – | 54,615 | – | 2.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |